|
The Nevada Psychological Association
in collaboration with the Utah Psychological Association
presents
Psychedelics in the Treatment of Psychiatric Disorders
Presented by Matthew Johnson, Ph.D.
Friday, March 24th, 2023
9:00am - 4:30pm PT
6 CE Credits
This workshop will be presented as a live, virtual presentation via Zoom webinar.
Participants will be able to communicate with the presenter in real-time during the course of instruction.
As participants can interact in real-time with the presenter, this webinar meets the requirements
as a live or face-to-face CE training by the State of Nevada Board of Psychological Examiners.
Approved for Nevada Psychologists, LCSWs and MFTs.
NPA is approved by the American Psychological Association to sponsor continuing education for psychologists. NPA maintains responsibility for this program and its content.
About the Workshop
This course will focus on the treatment of psychiatric disorders with psychedelics. We will cover historical and modern research suggesting treatment efficacy for psychedelic compounds for disorders such as addiction, depression, and cancer-related distress. Risks and methods for ensuring safety and maximizing efficacy will be explored. We will discuss patient selection, preparation, monitoring (guiding) during psychedelic sessions, and follow-up discussion (integration), among other topics relevant to psychedelic therapy.
Learning Objectives
At the end of this program, participants will be able to:
1. Identify two risk factors that require mitigation in clinical research with high doses of psilocybin or other classic psychedelic compounds
2. Describe two "classic psychedelic" compounds
3. Identify the current state of ethnic diversity in psychedelic therapy research
4. List two environmental factors that are involved in psychedelic therapy
About the Speaker
 Matthew W. Johnson, Ph.D., is The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics since 2004, he is one of the world’s most widely published experts on psychedelics. He has published research on psychedelics and mystical experience, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. In 2021 he received as principal investigator the first grant in 50 years from the US government for a treatment study with a classic psychedelic, specifically psilocybin in treatment of tobacco addiction. He is also known for his expertise in behavioral economics, addiction, sexual risk behavior, and research with a wide variety of drug classes. He’s been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, CNN, NPR, Fox News, Fox Business News, BBC and in Michael Pollan’s book How to Change Your Mind. Dr. Johnson's CV
Audience
This presentation is intended for psychologists, other licensed mental health providers, and graduate students of psychology.
Registration Fees
NPA Member $150.00 (Early Bird Discount $125.00 valid until 12/28/22)
Non-Member $195.00 (Early Bird Discount $160.00 valid until 12/28/22)
Student NPA Member $0.00 (Student NPA members can attend our live, virtual trainings for n/c with discount code)
Student Non-Member $80.00
General Information
Zoom Login Link and Handout Materials:
Zoom webinar login link and Handout materials will be sent out electronically to all attendees no later than one week prior to workshop date. Printed handout materials are not available for purchase as this CE training is being offered remotely.
Workshop Location:
Live, virtual webinar via Zoom webinar.
Closed Captions
Live audio captions will be provided for this event. If you need additional disability-related accommodations, please contact us by email us at [email protected] or by phone (888) 654-0050. Requests should be made at least two weeks in advance of workshop date.
Refunds & Grievance Policy: Participants may direct questions or grievances to NPA at (888) 654-0050. An administrative fee of $30 will be charged for cancellation of registration. Please note, no refunds will be granted after March 10th, 2023.
Approval
Approved by Nevada Board of Psychological Examiners. Nevada Psychological Association (NPA) is approved by the American Psychological Association to offer continuing education for psychologists. NPA maintains responsibility for the program and its content. NPA will issue certificates of completion. APA CE rules require that we only issue credits to those who attend the entire workshop. Attendance is strictly monitored. Those logging into the webinar more than 15 minutes late or logging off before the entire workshop is completed will not receive CE credits (i.e. partial credit will not be given).
References
Johnson MW. Consciousness, religion, and gurus: Pitfalls of psychedelic medicine. ACS Pharmacology & Translational Science. 2020;4(2):578-81.
Johnson, Matthew W. "Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation." Disruptive Psychopharmacology (2022): 213-227.
Johnson MW. Psychiatry might need some psychedelic therapy. Introduction to issue: The renaissance in psychedelic research. Int Rev Psychiatry. 2018;30(4):285-90.
There is no potential conflict of interest and/or commercial support for this program or its presenter.
|
